$391 Million is the total value of 5AM Venture Management, LLC's 24 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ENTRADA THERAPEUTICS INC | $63,921,496 | +7.2% | 4,408,379 | 0.0% | 16.35% | +2.1% | ||
| VOR | VOR BIOPHARMA INC | $34,226,070 | -19.1% | 6,361,723 | 0.0% | 8.75% | -23.0% | |
| CRNX | CRINETICS PHARMACEUTICALS IN | $13,848,313 | -12.2% | 862,286 | 0.0% | 3.54% | -16.5% | |
| DISC MEDICINE INC | $12,469,086 | +6.5% | 588,442 | 0.0% | 3.19% | +1.4% | ||
| RNA | AVIDITY BIOSCIENCES INC | $10,216,269 | -30.8% | 665,555 | 0.0% | 2.61% | -34.2% | |
| ARVN | ARVINAS INC | $8,742,400 | -20.1% | 320,000 | 0.0% | 2.24% | -24.0% | |
| COGT | COGENT BIOSCIENCES INC | $8,528,848 | -6.7% | 790,440 | 0.0% | 2.18% | -11.2% | |
| ANAB | ANAPTYSBIO INC | $7,784,270 | -29.8% | 357,733 | 0.0% | 1.99% | -33.2% | |
| PHVS | PHARVARIS N V | $4,733,118 | -28.4% | 587,600 | 0.0% | 1.21% | -31.9% | |
| FIXX | HOMOLOGY MEDICINES INC | $4,671,997 | -18.3% | 4,535,919 | 0.0% | 1.20% | -22.2% | |
| PEAR THERAPEUTICS INC | $4,269,749 | -78.4% | 16,744,113 | 0.0% | 1.09% | -79.4% | ||
| IMPL | IMPEL PHARMACEUTICALS INC | $4,038,707 | -62.7% | 2,884,791 | 0.0% | 1.03% | -64.5% | |
| CDTX | CIDARA THERAPEUTICS INC | $1,440,829 | +67.9% | 1,134,511 | 0.0% | 0.37% | +59.3% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-05-15
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| HOMOLOGY MEDICINES INC | 16 | Q3 2023 | 26.6% |
| ARVINAS INC | 16 | Q3 2023 | 14.3% |
| Crinetics Pharmaceuticals, Inc. | 16 | Q3 2023 | 12.8% |
| SCPHARMACEUTICALS INC | 16 | Q3 2023 | 7.5% |
| CIDARA THERAPEUTICS INC | 16 | Q3 2023 | 1.7% |
| IDEAYA BIOSCIENCES INC | 14 | Q1 2023 | 11.4% |
| VOR BIOPHARMA INC | 11 | Q3 2023 | 51.9% |
| CABALETTA BIO INC | 11 | Q2 2022 | 14.2% |
| AKOUOS INC | 10 | Q3 2022 | 27.7% |
| IMPEL PHARMACEUTICALS INC | 10 | Q3 2023 | 7.1% |
View 5AM Venture Management, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-03 |
| 13F-HR | 2021-11-15 |
View 5AM Venture Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.